Abstract

As a nodal mediator of pyruvate metabolism, the mitochondrial pyruvate carrier (MPC) plays a pivotal role in many physiological and pathological processes across the human lifespan, from embryonic development to aging-associated neurodegeneration. Emerging research highlights the importance of the MPC in diverse conditions, such as immune cell activation, cancer cell stemness, and dopamine production in Parkinson’s disease models. Whether MPC function ameliorates or contributes to disease is highly specific to tissue and cell type. Cell- and tissue-specific differences in MPC content and activity suggest that MPC function is tightly regulated as a mechanism of metabolic, cellular, and organismal control. Accordingly, recent studies on cancer and diabetes have identified protein–protein interactions, post-translational processes, and transcriptional factors that modulate MPC function. This growing body of literature demonstrates that the MPC and other mitochondrial carriers comprise a versatile and dynamic network undergirding the metabolism of health and disease.

Highlights

  • The mitochondrial pyruvate carrier (MPC) was discovered in 2012 [1,2]

  • Mitochondrial pyruvate metabolism is controlled by a triumvirate of enzymes—the MPC, pyruvate dehydrogenase (PDH), and pyruvate carboxylase (PC) [6,7,8]—that together modulate many physiological and pathological processes

  • Some cancers exhibit increased MPC expression and predominantly rely on oxidative phosphorylation to support growth. This difference could be due to the metabolism of surrounding tumor tissue, tissue type, the oxygenation and blood supply of the tumor microenvironment, and the accessibility of immune cells, all of which affect the energy metabolism of a tumor and can determine whether the MPC is a mediator of pro- or anti-cancer effects

Read more

Summary

Introduction

As early as 1971, studies predicted that a mitochondrial protein transported pyruvate from the cytoplasm into the mitochondria [3,4,5]. Smaller yet important niches for MPC research are becoming evident, highlighting the variety of situations where the MPC controls metabolism and dependent cellular functions. Some of these include embryonic and fetal health, stem cell development, neurogenerative disease, and immune cell function. Cell- and tissue-dependent differences in MPC content and activity suggest that MPC function is tightly regulated as a mechanism of metabolic, cellular, and organismal control. We examine MPC function across the lifespan, beginning with embryonic and fetal development and ending with aging-associated neurodegeneration

The MPC in the Triumvirate of Mitochondrial Pyruvate Metabolism
Embryonic and Fetal Health
Stem Cells
Cancer
MPC Disruption Promotes Cancer Progression
MPC Disruption Inhibits Cancer Progression
Pathology Associated with Immune Cell Function
Pathology Associated with Retinal and Visual Function
Neurogenerative Diseases
MPC Disruption is Protective in Neurodegenerative Disease
Regulation of MPC Expression or Activity
Findings
Conclusions and Future Directions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.